v3.25.1
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Non-Current Assets    
Deferred offering costs $ 418,728 $ 436,025
Total Assets 418,728 436,025
Current Liabilities    
Accrued expenses 285,411 407,039
Due to related party 251,803 72,773
Total Current Liabilities 537,214 479,812
Total Liabilities 537,214 479,812
Shareholder’s Deficit    
Preference shares, $0.0001 par value; 1,500,000 shares authorized; none issued or outstanding
Additional paid-in capital 24,425 24,425
Accumulated deficit (143,486) (68,787)
Total Shareholder’s Deficit (118,486) (43,787)
TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT 418,728 436,025
Common Class A [Member]    
Shareholder’s Deficit    
Common Stock, Value
Common Class B [Member]    
Shareholder’s Deficit    
Common Stock, Value [1] $ 575 $ 575
[1] Includes 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 7). On May 2, 2025, the Company consummated its Initial Public Offering and sold 17,250,000 Units, including 2,250,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover the over-allotment, hence the 750,000 Class B ordinary shares are no longer subject to forfeiture.